Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL62P is a non-functional pseudogene in the human genome representing a defunct copy of a gene encoding 7SL RNA, a critical RNA component of the signal recognition particle (SRP) ribonucleoprotein complex. While functional 7SL RNA is involved in co-translational targeting of proteins to the endoplasmic reticulum, pseudogenes like RN7SL62P usually arise through reverse transcription and genomic integration of RNA molecules. They are typically characterized by their lack of functional gene products and their frequent truncation or mutation relative to their parent sequence[1][4][7]. Pseudogenes are generally nonfunctional; however, rare regulatory functions for pseudogenes are described in other contexts, though none are known for RN7SL62P. There is no evidence that RN7SL62P is expressed or has a known regulatory or disease-associated role. While parental 7SL RNA or its derivatives may be implicated in cancer or neurodegenerative disease, there is no specific role described for RN7SL62P[1][5]. Most pseudogenes, including this one, are not considered therapeutic targets nor are they involved in known drug interactions. Pseudogenes are commonly found in the genome, often created by retrotransposition or gene duplication, but lack protein-coding potential or regulatory activity unless specifically shown otherwise[4][7]. 7SL RNA pseudogenes, including RN7SL62P, are numerous and typically lack the structural integrity needed for SRP function[7]. Any functional or disease relevance described for 7SL RNA or signal recognition particle does not apply to RN7SL62P[5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 62, pseudogene (RN7SL62P).